SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix shares are experiencing significant volatility as investors weigh record-breaking quarterly revenue against earnings results that fell slightly short of analyst estimates. The stock remains a focal point of intense community discussion, with traders debating whether the downward pressure is a temporary reaction to inflated expectations or a signal of broader weakness in the memory chip sector.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors react to a violent sector-wide sell-off in memory and semiconductor stocks driven by macro uncertainty, geopolitical tensions, and fear-mongering regarding Chinese competition. The community is actively debating whether to buy the dip based on strong underlying fundamentals and institutional support, or to remain cautious as traders monitor pivotal earnings releases from peers like SK Hynix and Seagate.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is facing intense bearish sentiment and significant volatility as investors brace for earnings alongside broader macro uncertainty from potential Federal Reserve rate decisions. Community discussion is dominated by deep skepticism over management's past guidance and dilution, though some investors remain committed to the long-term growth story, actively looking to accumulate shares ahead of the upcoming report.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently a major focus for investors as the company just reported blowout second-quarter earnings that significantly exceeded revenue and earnings estimates while raising full-year guidance. The community is actively debating the stock's future, with many bullish traders viewing the recent price pullback as an attractive entry point driven by the company's vital role in powering the AI infrastructure supercycle.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is experiencing a sharp sell-off as investors react to a memory sector rout fueled by broader market volatility and concerns over increased competition, leading the community to actively debate whether this represents a terminal bubble or a prime opportunity to buy the dip ahead of upcoming earnings. While many retail traders are grappling with significant losses and questioning the stock's stability, others are aggressively sizing up positions, dismissing the recent price action as a temporary distortion driven by institutional margin liquidations and algorithmic manipulation rather than fundamental deterioration.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as retail sentiment remains deeply divided between those betting on an AI-driven relief rally following geopolitical news and others warning of structural decay in leveraged ETFs. The community is heavily focused on the disconnect between strong long-term semiconductor fundamentals and the aggressive, news-driven sell-offs that have triggered widespread margin concerns.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as market participants grapple with shifting macroeconomic data, Middle East geopolitical tensions, and looming FOMC interest rate decisions. Community discussions are split between those executing short-term 'V-shaped' recovery trades and those warning of deeper structural weaknesses within AI-linked sectors.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

Seagate Technology is trending as investors react to strong quarterly earnings, where the company highlighted robust AI-driven cloud data center demand and provided revenue and EPS guidance that exceeded consensus estimates. Community discourse is currently split between optimism over the company's long-term storage demand roadmap and skepticism regarding potential semiconductor cyclicality and high valuations.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are actively debating the potential impacts of renewed geopolitical tension following reports of Iranian missile activity, while closely monitoring upcoming FOMC interest rate decisions. Community sentiment is deeply split, with traders focused on volatility and speculative scalping in a market currently struggling to break through key resistance levels.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is currently in the spotlight as investors analyze its long-term strategic supply agreement with Micron, which secures critical memory and storage for next-generation vehicle platforms. Meanwhile, market sentiment is oscillating as the company navigates ongoing quality control hurdles and mixed sales data, with the community actively debating whether Fords transition into energy storage solutions and commercial data center power can effectively offset legacy automotive headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VRDN Stock Rises 6.3% in a Week: Here's What You Need to Know

Viridian enters the commercial stage after FDA approval of Lumvoa for thyroid eye disease, with expanded labeling and plans for an immediate U.S. launch.

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease

FDA approves Viridian Therapeutics' Lumvoa for thyroid eye disease. Immediate commercial launch scheduled with full patient support.read more...

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization. $UPC, $NTHI, $DCOY, $VRDN

Futures Rise As Dip-Buyers Lift Tech Stocks

Futures Rise As Dip-Buyers Lift Tech Stocks

 US equity futures are higher led by Tech as Mag7 leads the group higher and points to a reversal of last week's profit-taking, as traders position for the end of the first half. A shortened week will likely focus on a speech from the Fed's...

Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday

U.S. stock futures up, watch Concentrix Corp, Lantheus Holdings, AeroVironment, Viridian Therapeutics, Universe Pharmaceuticals for earnings and news.read more...

VRDN Stock Jumps 6% After-Hours As Viridian Wins First FDA Approval  

Equity

The FDA approved Viridian’s Lumvoa for the treatment of thyroid eye disease. 


Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa (veligrotug-vvze) for the Treatment of Thyroid Eye Disease

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Lumvoa (veligrotug-vvze...

Viridian Therapeutics to Participate in Upcoming June Investor Conferences

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced that members of its management team will participate in the following upcoming investor...

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today...

Viridian Therapeutics (NASDAQ:VRDN) Given "Buy" Rating at Needham & Company LLC

Needham & Company LLC reaffirmed a "buy" rating and set a $32.00 price target on shares of Viridian Therapeutics in a research report on Tuesday...

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$19.51
Prev Close	$19.70
Open	$19.67
Dividend Yield	0.00%
50-Day Moving Average	$17.72
Beta	1.16
Avg. Volume	2.29M
PE Ratio	-5.23

52-Week High	$34.29
52-Week Low	$13.18
Market Capitalization	$2.18B
EPS (Annual)	-$3.32
Price to Book	4.01
Revenue Per Employee	$281,146.83

Feed

News

Sentiment

Earnings

Fundamentals

Info

VRDNViridian Therapeutics Inc

Latest VRDN News